Scholar Rock Holding (SRRK) Current Leases (2018 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Current Leases of $6.1 million in Q1 2026, up 9.48% quarter-over-quarter from $5.6 million in Q4 2025, and up 10.53% on a YoY basis from $5.5 million in Q1 2025.
Scholar Rock Holding (SRRK) Current Leases (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Current Leases history runs 9 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Current Leases rose 10.53% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 10.53% YoY), while the FY2025 annual figure was $5.6 million, down 3.88% from the prior year.
- Current Leases was $6.1 million for Q1 2026 at Scholar Rock Holding, up from $5.6 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.1 million in Q3 2022 to a low of $5.2 million in Q2 2025.
- Historically, Current Leases has averaged $6.7 million across 5 years, with a median of $7.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Current Leases soared 34.41% in 2022, then declined 27.85% in 2025.
- A 5-year view of Current Leases shows it stood at $7.9 million in 2022, then decreased by 5.65% to $7.4 million in 2023, then retreated by 22.06% to $5.8 million in 2024, then fell by 3.88% to $5.6 million in 2025, then climbed by 9.48% to $6.1 million in 2026.
- The last three Current Leases figures came in at $6.1 million (Q1 2026), $5.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 6.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.08 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 7.64 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 7.00 Mn |